Related Experiment Videos
Disseminated melanoma--is there a new standard therapy?
The New England Journal of Medicine
|August 30, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis.
British journal of cancer·2006
Early stage (I, II, III) melanoma.
Current treatment options in oncology·2002
Metastatic melanoma.
Current treatment options in oncology·2002
Review of the 2001 AJCC staging system for cutaneous malignant melanoma.
Current oncology reports·2001
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution study.
Annals of plastic surgery·2001
Response-Tailored or Standard-Duration Antibiotic Treatment for Infective Endocarditis.
The New England journal of medicine·2026
Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
The New England journal of medicine·2026
Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk.
The New England journal of medicine·2026
Eplontersen for Transthyretin Amyloid Cardiomyopathy.
The New England journal of medicine·2026
Myeloproliferative Neoplasms.
The New England journal of medicine·2026
A marine-derived meroterpenoid inhibits colorectal cancer via PI3K pathway modulation in mice.
Marine life science & technology·2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Journal of molecular and cellular cardiology plus·2026